全文获取类型
收费全文 | 2694篇 |
免费 | 200篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 181篇 |
妇产科学 | 33篇 |
基础医学 | 329篇 |
口腔科学 | 107篇 |
临床医学 | 293篇 |
内科学 | 595篇 |
皮肤病学 | 120篇 |
神经病学 | 131篇 |
特种医学 | 430篇 |
外科学 | 185篇 |
综合类 | 54篇 |
一般理论 | 1篇 |
预防医学 | 132篇 |
眼科学 | 24篇 |
药学 | 132篇 |
2篇 | |
肿瘤学 | 216篇 |
出版年
2021年 | 25篇 |
2020年 | 26篇 |
2019年 | 24篇 |
2018年 | 43篇 |
2017年 | 33篇 |
2016年 | 33篇 |
2015年 | 53篇 |
2014年 | 60篇 |
2013年 | 83篇 |
2012年 | 60篇 |
2011年 | 73篇 |
2010年 | 112篇 |
2009年 | 99篇 |
2008年 | 87篇 |
2007年 | 116篇 |
2006年 | 89篇 |
2005年 | 98篇 |
2004年 | 59篇 |
2003年 | 42篇 |
2002年 | 44篇 |
2001年 | 52篇 |
2000年 | 60篇 |
1999年 | 48篇 |
1998年 | 134篇 |
1997年 | 160篇 |
1996年 | 138篇 |
1995年 | 111篇 |
1994年 | 120篇 |
1993年 | 102篇 |
1992年 | 52篇 |
1991年 | 54篇 |
1990年 | 55篇 |
1989年 | 70篇 |
1988年 | 58篇 |
1987年 | 55篇 |
1986年 | 57篇 |
1985年 | 51篇 |
1984年 | 33篇 |
1983年 | 24篇 |
1982年 | 29篇 |
1981年 | 34篇 |
1980年 | 29篇 |
1979年 | 12篇 |
1978年 | 12篇 |
1977年 | 23篇 |
1976年 | 29篇 |
1975年 | 20篇 |
1971年 | 7篇 |
1969年 | 7篇 |
1966年 | 9篇 |
排序方式: 共有2969条查询结果,搜索用时 578 毫秒
81.
82.
W. Andonotopo M. Stanojevic A. Kurjak G. Azumendi JM Carrera 《The Ultrasound Review of Obstetrics & Gynecology》2004,4(2):103-114
The aim of this paper was to review the clinical applications of four-dimensional ultrasonography in the assessment of fetal behavior. With the use of a computerized database, articles on three-dimensional ultrasonography were reviewed. Several applications of dynamic three-dimensional ultrasonography have been reported, including imaging of fetal movements, facial expression and fetal hand movements. The importance of the assessment of fetal behavior by four-dimensional sonography is stressed. Four-dimensional sonography seems to be a useful imaging tool for clinical problem solving in perinatology, especially in observing the development of the central nervous system in utero. 相似文献
83.
84.
85.
86.
SB Cho JH Kim S Cho JM Park YK Park SH Oh 《Journal of the European Academy of Dermatology and Venereology》2011,25(1):64-67
Background The clinical characteristics of vitiligo in children and adolescents with an emphasis on thyroid dysfunction have only been reported in a few studies. Objective The purpose of this study was to examine the characteristics of children and adolescents with vitiligo and compare the incidence of thyroid dysfunction between them and controls without vitiligo at the same age. Methods A retrospective analysis of 324 Korean children and adolescents with vitiligo was performed. The results of thyroid function screening tests in them (n = 254) were compared with controls (n = 122). Results Of the total 324 children and adolescents with vitiligo, vitiligo vulgaris was the most common type (42.3%) and the most commonly involved site was the face (54.6%). A total of 15 of 254 (5.9%) patients screened for thyroid function were diagnosed with thyroid disease (four had Hashimoto’s thyroiditis; two, Graves’ disease; seven, subclinical hypothyroidism; and two, subclinical hyperthyroidism). None of the 50 patients with segmental vitiligo showed any thyroid dysfunction (P = 0.047). There was no significant difference in the incidence of thyroid disease between children and adolescents with vitiligo and the control group, in which seven of 122 (5.7%) showed thyroid dysfunction. Conclusion In this study, we demonstrated the characteristics of children and adolescents with vitiligo and also observed no significant difference in the incidence of thyroid disease between children and adolescents with vitiligo and the control group. 相似文献
87.
88.
J.M. Batchelor A. Chapman F.E. Craig K.E. Harman G. Kirtschig A. Martin‐Clavijo A.D. Ormerod S. Walton H.C. Williams 《The British journal of dermatology》2017,177(5):e228-e234
Clinical trials may benefit clinical practice in three ways: firstly, clinicians may change their practice according to the new trial evidence; secondly, clinical processes can improve when working on a trial; and thirdly, research capacity is increased. We held a meeting to present and discuss the results of two large multicentre randomized controlled trials delivered through the U.K. Dermatology Clinical Trials Network. Investigators gave reflections on how the trials had changed their clinical practice. The STOP GAP trial showed that prednisolone and ciclosporin are equally effective as first‐line systemic treatment for pyoderma gangrenosum. The final decision of which treatment to use should be based on the different adverse event profiles of the two drugs in relation to comorbidities, along with age, disease severity and patient preference. The BLISTER trial showed that starting people with pemphigoid on doxycycline produces acceptable short‐term effectiveness and a superior safety profile to oral corticosteroids. Recruiting to these trials has led to the development of new specialist clinics with improved documentation. It has increased the profile of participating departments and embedded research in the department's activities. Helping to design and run these trials has also allowed trial staff to develop new skills in research design, which has been beneficial for career development. These and other benefits of recruiting to the trials are summarized here. We hope that these reflections will inspire wider involvement in clinical research. 相似文献
89.
Nancy Henne Batchelor MSN RN CNS 《Rehabilitation nursing》2010,35(2):60-64
With advances in health care and medical technology, the focus of medical care has been on curing. As people live longer, the possibility of experiencing chronic and life‐limiting disease not only increases but also spurs the ethical question “Is length of life or quality of life most important?” Palliative care may be confused with hospice care, as both focus on symptom management and improved quality of life for those with chronic life‐limiting disease. A better understanding of each healthcare option is needed for appropriate and timely patient referral. The purpose of this article is to identify the similarities and differences between these two options, clarify when referral is appropriate for hospice or palliative care services, and discuss the nurse's role in caring for patients with chronic disease. 相似文献
90.
de Haas M; Kerst JM; van der Schoot CE; Calafat J; Hack CE; Nuijens JH; Roos D; van Oers RH; von dem Borne AE 《Blood》1994,84(11):3885-3894
In four healthy volunteers, we analyzed in detail the immediate in vivo effects on circulating neutrophils of subcutaneous administration of 300 micrograms of granulocyte colony-stimulating factor (G-CSF). Neutrophil activation was assessed by measurement of degranulation. Mobilization of secretory vesicles was shown by a decrease in leukocyte alkaline phosphatase content of the circulating neutrophils. Furthermore, shortly postinjection, Fc gamma RIII was found to be upregulated from an intracellular pool that we identified by immunoelectron microscopy as secretory vesicles. Intravascular release of specific granules was shown by increased plasma levels of lactoferrin and by upregulation of the expression of CD66b and CD11b on circulating neutrophils. Moreover, measurement of fourfold elevated plasma levels of elastase, bound to its physiologic inhibitor alpha 1- antitrypsin, indicated mobilization of azurophil granules. However, no expression of CD63, a marker of azurophil granules, was observed on circulating neutrophils. G-CSF--induced mobilization of secretory vesicles and specific granules could be mimicked in whole blood cultures in vitro, in contrast to release of azurophil granules. Therefore, we postulate that the most activated neutrophils leave the circulation, as observed shortly postinjection, and undergo subsequent stimulation in the endothelial microenvironment, resulting in mobilization of azurophil granules. Our data demonstrate that G-CSF should be regarded as a potent immediate activator of neutrophils in vivo. 相似文献